In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...

At the Cleveland Clinic, researchers are testing a preventive breast cancer vaccine, and results from Phase 1 of the trial are showing promising signs.

In a Phase 1 trial, women responded well to the novel vaccine. More research is needed to determine whether it can stop the ...

So in summary, HER2CLIMB-05 was a positive study. It showed that adding tucatinib for both HR-positive as well as HR-negative ...

Tukysa, combined with Herceptin and Perjeta, extends progression-free survival in HER2+ metastatic breast cancer, showing ...

Working the night shift, frequently flying across time zones or keeping an irregular sleep schedule does more than just leave ...

Bang Bang” singer Jessie J, 37, has been center stage this year not just for her performances, but because she’s sharing her ...

Angelina Jolie shows mastectomy scars to spotlight breast health on TIME France. The Oscar-winning actor appears on the first ...

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine.

Parma Medical Center recently opened its new $3.5 million Breast Health Center at the UH Parma Medical Arts Center 4 building ...

New ultrasound technology developed at Johns Hopkins can distinguish fluid from solid breast masses with near perfect ...

Tailoring breast cancer screening to a woman's individual cancer risk might work better than annual mammograms, researchers ...